{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T00:02:49Z","timestamp":1794009769474,"version":"4.8.0"},"reference-count":46,"publisher":"BMJ","issue":"3","license":[{"start":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T00:00:00Z","timestamp":1759190400000},"content-version":"unspecified","delay-in-days":91,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"ASPET Summer Intern Program"},{"DOI":"10.13039\/100000738","name":"Department of Veteran Affairs","doi-asserted-by":"crossref","award":["BX002741"],"award-info":[{"award-number":["BX002741"]}],"id":[{"id":"10.13039\/100000738","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["DK122725"],"award-info":[{"award-number":["DK122725"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["DK137451"],"award-info":[{"award-number":["DK137451"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000066","name":"National Institute of Environmental Health Sciences","doi-asserted-by":"publisher","award":["ES005022"],"award-info":[{"award-number":["ES005022"]}],"id":[{"id":"10.13039\/100000066","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000066","name":"National Institute of Environmental Health Sciences","doi-asserted-by":"publisher","award":["ES007148"],"award-info":[{"award-number":["ES007148"]}],"id":[{"id":"10.13039\/100000066","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000066","name":"National Institute of Environmental Health Sciences","doi-asserted-by":"publisher","award":["ES020721"],"award-info":[{"award-number":["ES020721"]}],"id":[{"id":"10.13039\/100000066","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000066","name":"National Institute of Environmental Health Sciences","doi-asserted-by":"publisher","award":["ES029258"],"award-info":[{"award-number":["ES029258"]}],"id":[{"id":"10.13039\/100000066","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Rutgers University Center for Lipid Research"},{"DOI":"10.13039\/100000057","name":"National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["GM135258"],"award-info":[{"award-number":["GM135258"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["egastro"],"accepted":{"date-parts":[[2025,9,4]]},"published-print":{"date-parts":[[2025,7]]},"abstract":"<jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Farnesoid X receptor (FXR) has been identified as a therapeutic target for metabolic dysfunction-associated steatohepatitis (MASH). Hepatic FXR is especially critical in suppressing liver inflammation. FXR agonism and antagonism have both proven to be beneficial in the mitigation of MASH, leading to much controversy in the field, particularly regarding FXR signalling in the gut. The objective of this study was to determine the effects of ursodeoxycholic acid (UDCA), a postulated gut FXR antagonist with liver protective effects, on the mitigation and prevention of MASH development in mice with hepatic FXR deficiency.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>For this experiment, six-week-old to eight\u2009week-old male and female liver-specific FXR knockout (FXR<jats:sup>hep-\/-<\/jats:sup>) and control (FXR<jats:sup>hep flox\/flox<\/jats:sup>) mice were fed either a low-fat control diet (CTL) or a MASH \u2018Fast Food\u2019 diet (Western diet with 21% milk fat, 1.25% cholesterol and 34% sucrose) both supplemented with or without 0.1% (weight\/weight; w\/w) UDCA for 16 weeks.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>UDCA feeding tended to reduce alanine aminotransferase levels and decrease liver lipids in the male mice. Supplementation of UDCA showed a trend towards increased UDCA and tauroursodeoxycholic acid (TUDCA) levels in serum, liver and intestine, although the male mice displayed more than twice the amount of these bile acids compared with the female mice. CTL-UDCA feeding resulted in a significant induction of <jats:italic>Fxr<\/jats:italic> and <jats:italic>Fgf15<\/jats:italic> mRNA expression in the ileum of the male mice.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>The data strongly suggest that UDCA seems to act as an FXR agonist, especially in the ileum, which contrasts with previous reports that UDCA acts as a gut FXR antagonist. In addition, UDCA seems to be exerting liver protective effects predominantly in the male mice.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1136\/egastro-2025-100227","type":"journal-article","created":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T06:00:20Z","timestamp":1759212020000},"page":"e100227","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":12,"title":["Ursodeoxycholic acid acts as an ileal FXR agonist in male mice with hepatic deficiency of FXR"],"prefix":"10.1136","volume":"3","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6272-8115","authenticated-orcid":false,"given":"Zakiyah R","family":"Henry","sequence":"first","affiliation":[{"name":"Pharmacology and Toxicology, Rutgers University, Piscataway, New Jersey, USA"},{"name":"Environmental and Occupational Health Science Institute, Rutgers University, Piscataway, New Jersey, USA"},{"name":"Rutgers Center for Lipid Research, Rutgers University, New Brunswick, New Jersey, USA"},{"name":"Ernest Mario School of Pharmacy, Rutgers University, Piscataway, New Jersey, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Syeda","family":"Maliha","sequence":"additional","affiliation":[{"name":"Ernest Mario School of Pharmacy, Rutgers University, Piscataway, New Jersey, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veronia","family":"Basaly","sequence":"additional","affiliation":[{"name":"Pharmacology and Toxicology, Rutgers University, Piscataway, New Jersey, USA"},{"name":"Environmental and Occupational Health Science Institute, Rutgers University, Piscataway, New Jersey, USA"},{"name":"Rutgers Center for Lipid Research, Rutgers University, New Brunswick, New Jersey, USA"},{"name":"Ernest Mario School of Pharmacy, Rutgers University, Piscataway, New Jersey, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenning","family":"Yang","sequence":"additional","affiliation":[{"name":"Pharmacology and Toxicology, Rutgers University, Piscataway, New Jersey, USA"},{"name":"Environmental and Occupational Health Science Institute, Rutgers University, Piscataway, New Jersey, USA"},{"name":"Rutgers Center for Lipid Research, Rutgers University, New Brunswick, New Jersey, USA"},{"name":"Ernest Mario School of Pharmacy, Rutgers University, Piscataway, New Jersey, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rulaiha E","family":"Taylor","sequence":"additional","affiliation":[{"name":"Pharmacology and Toxicology, Rutgers University, Piscataway, New Jersey, USA"},{"name":"Environmental and Occupational Health Science Institute, Rutgers University, Piscataway, New Jersey, USA"},{"name":"Rutgers Center for Lipid Research, Rutgers University, New Brunswick, New Jersey, USA"},{"name":"Ernest Mario School of Pharmacy, Rutgers University, Piscataway, New Jersey, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine","family":"Otersen","sequence":"additional","affiliation":[{"name":"Pharmacology and Toxicology, Rutgers University, Piscataway, New Jersey, USA"},{"name":"Environmental and Occupational Health Science Institute, Rutgers University, Piscataway, New Jersey, USA"},{"name":"Rutgers Center for Lipid Research, Rutgers University, New Brunswick, New Jersey, USA"},{"name":"Ernest Mario School of Pharmacy, Rutgers University, Piscataway, New Jersey, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vik","family":"Meadows","sequence":"additional","affiliation":[{"name":"Pharmacology and Toxicology, Rutgers University, Piscataway, New Jersey, USA"},{"name":"Environmental and Occupational Health Science Institute, Rutgers University, Piscataway, New Jersey, USA"},{"name":"Ernest Mario School of Pharmacy, Rutgers University, Piscataway, New Jersey, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Rizzolo","sequence":"additional","affiliation":[{"name":"Pharmacology and Toxicology, Rutgers University, Piscataway, New Jersey, USA"},{"name":"Environmental and Occupational Health Science Institute, Rutgers University, Piscataway, New Jersey, USA"},{"name":"Rutgers Center for Lipid Research, Rutgers University, New Brunswick, New Jersey, USA"},{"name":"Ernest Mario School of Pharmacy, Rutgers University, Piscataway, New Jersey, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary","family":"Stofan","sequence":"additional","affiliation":[{"name":"Pharmacology and Toxicology, Rutgers University, Piscataway, New Jersey, USA"},{"name":"Environmental and Occupational Health Science Institute, Rutgers University, Piscataway, New Jersey, USA"},{"name":"Rutgers Center for Lipid Research, Rutgers University, New Brunswick, New Jersey, USA"},{"name":"Ernest Mario School of Pharmacy, Rutgers University, Piscataway, New Jersey, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anisha","family":"Bhattacharya","sequence":"additional","affiliation":[{"name":"Pharmacology and Toxicology, Rutgers University, Piscataway, New Jersey, USA"},{"name":"Environmental and Occupational Health Science Institute, Rutgers University, Piscataway, New Jersey, USA"},{"name":"Ernest Mario School of Pharmacy, Rutgers University, Piscataway, New Jersey, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peihong","family":"Zhou","sequence":"additional","affiliation":[{"name":"Environmental and Occupational Health Science Institute, Rutgers University, Piscataway, New Jersey, USA"},{"name":"Ernest Mario School of Pharmacy, Rutgers University, Piscataway, New Jersey, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anita","family":"Brinker","sequence":"additional","affiliation":[{"name":"Environmental and Occupational Health Science Institute, Rutgers University, Piscataway, New Jersey, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ill","family":"Yang","sequence":"additional","affiliation":[{"name":"Environmental and Occupational Health Science Institute, Rutgers University, Piscataway, New Jersey, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lanjing","family":"Zhang","sequence":"additional","affiliation":[{"name":"Ernest Mario School of Pharmacy, Rutgers University, Piscataway, New Jersey, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurie B","family":"Joseph","sequence":"additional","affiliation":[{"name":"Pharmacology and Toxicology, Rutgers University, Piscataway, New Jersey, USA"},{"name":"Environmental and Occupational Health Science Institute, Rutgers University, Piscataway, New Jersey, USA"},{"name":"Rutgers Center for Lipid Research, Rutgers University, New Brunswick, New Jersey, USA"},{"name":"Ernest Mario School of Pharmacy, Rutgers University, Piscataway, New Jersey, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"Buckley","sequence":"additional","affiliation":[{"name":"Pharmacology and Toxicology, Rutgers University, Piscataway, New Jersey, USA"},{"name":"Environmental and Occupational Health Science Institute, Rutgers University, Piscataway, New Jersey, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Kong","sequence":"additional","affiliation":[{"name":"Pharmacology and Toxicology, Rutgers University, Piscataway, New Jersey, USA"},{"name":"Environmental and Occupational Health Science Institute, Rutgers University, Piscataway, New Jersey, USA"},{"name":"Rutgers Center for Lipid Research, Rutgers University, New Brunswick, New Jersey, USA"},{"name":"Ernest Mario School of Pharmacy, Rutgers University, Piscataway, New Jersey, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grace L","family":"Guo","sequence":"additional","affiliation":[{"name":"Pharmacology and Toxicology, Rutgers University, Piscataway, New Jersey, USA"},{"name":"Environmental and Occupational Health Science Institute, Rutgers University, Piscataway, New Jersey, USA"},{"name":"Rutgers Center for Lipid Research, Rutgers University, New Brunswick, New Jersey, USA"},{"name":"Ernest Mario School of Pharmacy, Rutgers University, Piscataway, New Jersey, USA"},{"name":"Department of Veterans Affairs New Jersey Health Care System, East Orange, New Jersey, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2025,9,29]]},"reference":[{"key":"2025092923000965000_3.3.e100227.1","doi-asserted-by":"publisher","DOI":"10.1016\/j.mce.2022.111618"},{"key":"2025092923000965000_3.3.e100227.2","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/3589525","article-title":"Farnesoid X Receptor Deficiency Induces Hepatic Lipid and Glucose Metabolism Disorder via Regulation of Pyruvate Dehydrogenase Kinase 4","volume":"2022","author":"Deng","year":"2022","journal-title":"Oxid Med Cell Longev"},{"key":"2025092923000965000_3.3.e100227.3","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1007\/164_2019_228","article-title":"Pharmacologic Modulation of Bile Acid-FXR-FGF15\/FGF19 Pathway for the Treatment of Nonalcoholic Steatohepatitis","volume":"256","author":"Schumacher","year":"2019","journal-title":"Handb Exp Pharmacol"},{"key":"2025092923000965000_3.3.e100227.4","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1055\/a-2128-5538","article-title":"FXR Friend-ChIPs in the Enterohepatic System","volume":"43","author":"Meadows","year":"2023","journal-title":"Semin Liver Dis"},{"key":"2025092923000965000_3.3.e100227.5","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2023.11.001"},{"key":"2025092923000965000_3.3.e100227.6","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25115674"},{"key":"2025092923000965000_3.3.e100227.7","doi-asserted-by":"publisher","DOI":"10.1002\/hep.29466"},{"key":"2025092923000965000_3.3.e100227.8","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2018.09.014"},{"key":"2025092923000965000_3.3.e100227.9","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2011.06.061"},{"key":"2025092923000965000_3.3.e100227.10","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-024-02958-z"},{"key":"2025092923000965000_3.3.e100227.11","doi-asserted-by":"crossref","DOI":"10.1016\/j.mce.2022.111678","article-title":"Recent advances on FXR-targeting therapeutics","volume":"552","author":"Panzitt","year":"2022","journal-title":"Mol Cell Endocrinol"},{"key":"2025092923000965000_3.3.e100227.12","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-022-02200-8"},{"key":"2025092923000965000_3.3.e100227.13","doi-asserted-by":"publisher","DOI":"10.1002\/hep.31205"},{"key":"2025092923000965000_3.3.e100227.14","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000037271","article-title":"The effect and safety of obeticholic acid for patients with nonalcoholic steatohepatitis: A systematic review and meta-analysis of randomized controlled trials","volume":"103","author":"Zhao","year":"2024","journal-title":"Medicine (Baltimore)"},{"key":"2025092923000965000_3.3.e100227.15","article-title":"Deletion of hepatic FXR leads to more severe MASH development in female mice","volume":"9","author":"Henry","year":"2025","journal-title":"Hepatol Commun"},{"key":"2025092923000965000_3.3.e100227.16","doi-asserted-by":"publisher","DOI":"10.1038\/nm.3760"},{"key":"2025092923000965000_3.3.e100227.17","doi-asserted-by":"publisher","DOI":"10.1172\/JCI76738"},{"key":"2025092923000965000_3.3.e100227.18","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms10166","article-title":"Intestine-selective farnesoid X receptor inhibition improves obesity-related metabolic dysfunction","volume":"6","author":"Jiang","year":"2015","journal-title":"Nat Commun"},{"key":"2025092923000965000_3.3.e100227.19","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbadis.2018.05.011"},{"key":"2025092923000965000_3.3.e100227.20","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2014.12.034"},{"key":"2025092923000965000_3.3.e100227.21","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-018-0222-4"},{"key":"2025092923000965000_3.3.e100227.22","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2020.594496","article-title":"Ursodeoxycholic Acid Protects Against Arsenic Induced Hepatotoxicity by the Nrf2 Signaling Pathway","volume":"11","author":"Li","year":"2020","journal-title":"Front Pharmacol"},{"key":"2025092923000965000_3.3.e100227.23","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2024.116617","article-title":"A high-dose of ursodeoxycholic acid treatment alleviates liver inflammation by remodeling gut microbiota and bile acid profile in a mouse model of non-alcoholic steatohepatitis","volume":"174","author":"Li","year":"2024","journal-title":"Biomed Pharmacother"},{"key":"2025092923000965000_3.3.e100227.24","doi-asserted-by":"publisher","DOI":"10.1194\/jlr.R900011-JLR200"},{"key":"2025092923000965000_3.3.e100227.25","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMct074694"},{"key":"2025092923000965000_3.3.e100227.26","doi-asserted-by":"crossref","first-page":"2848","DOI":"10.1111\/bph.14705","article-title":"Ursodeoxycholic acid accelerates bile acid enterohepatic circulation","volume":"176","author":"Zhang","year":"2019","journal-title":"Br J Pharmacol"},{"key":"2025092923000965000_3.3.e100227.27","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2015.02.023"},{"key":"2025092923000965000_3.3.e100227.28","doi-asserted-by":"crossref","first-page":"12","DOI":"10.15386\/mpr-2629","article-title":"The therapeutic mechanisms and beneficial effects of ursodeoxycholic acid in the treatment of nonalcoholic fatty liver disease: a systematic review","volume":"97","author":"Stan","year":"2024","journal-title":"Med Pharm Rep"},{"key":"2025092923000965000_3.3.e100227.29","doi-asserted-by":"publisher","DOI":"10.1002\/hep.25740"},{"key":"2025092923000965000_3.3.e100227.30","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1093\/toxsci\/kfae029","article-title":"Characterization of individual bile acids in vivo utilizing a novel low bile acid mouse model","volume":"199","author":"Taylor","year":"2024","journal-title":"Toxicol Sci"},{"key":"2025092923000965000_3.3.e100227.31","doi-asserted-by":"crossref","first-page":"433","DOI":"10.4254\/wjh.v13.i4.433","article-title":"Bile acid indices as biomarkers for liver diseases I: Diagnostic markers","volume":"13","author":"Alamoudi","year":"2021","journal-title":"World J Hepatol"},{"key":"2025092923000965000_3.3.e100227.32","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/j.jcmgh.2020.12.004","article-title":"Cholangiopathy and Biliary Fibrosis in Cyp2c70-Deficient Mice Are Fully Reversed by Ursodeoxycholic Acid","volume":"11","author":"de Boer","year":"2021","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"2025092923000965000_3.3.e100227.33","first-page":"235","article-title":"Bile Acids, Their Receptors, and the Gut Microbiota","volume":"36","author":"Poland","year":"2021","journal-title":"Physiology (Bethesda)"},{"key":"2025092923000965000_3.3.e100227.34","doi-asserted-by":"crossref","DOI":"10.1186\/1746-4269-5-2","article-title":"Bear bile: dilemma of traditional medicinal use and animal protection","volume":"5","author":"Feng","year":"2009","journal-title":"J Ethnobiol Ethnomed"},{"key":"2025092923000965000_3.3.e100227.35","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-2275(20)35109-9"},{"key":"2025092923000965000_3.3.e100227.36","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1016\/S0022-2275(20)34421-7","article-title":"Physicochemical properties of bile acids and their relationship to biological properties: an overview of the problem","volume":"25","author":"Hofmann","year":"1984","journal-title":"J Lipid Res"},{"key":"2025092923000965000_3.3.e100227.37","first-page":"690","article-title":"Dissolution of cholesterol gallstones by long-term administration of ursodeoxycholic acid","volume":"72","author":"Makino","year":"1975","journal-title":"Nihon Shokakibyo Gakkai Zasshi"},{"key":"2025092923000965000_3.3.e100227.38","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1080\/1028415X.2017.1349359","article-title":"Control diet in a high-fat diet study in mice: Regular chow and purified low-fat diet have similar effects on phenotypic, metabolic, and behavioral outcomes","volume":"22","author":"Almeida-Suhett","year":"2019","journal-title":"Nutr Neurosci"},{"key":"2025092923000965000_3.3.e100227.39","doi-asserted-by":"crossref","DOI":"10.1186\/1755-1536-6-18","article-title":"The role of mouse strain differences in the susceptibility to fibrosis: a systematic review","volume":"6","author":"Walkin","year":"2013","journal-title":"Fibrogenesis Tissue Repair"},{"key":"2025092923000965000_3.3.e100227.40","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(97)80020-7"},{"key":"2025092923000965000_3.3.e100227.41","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1002\/hep.29145","article-title":"The role of long noncoding RNA H19 in gender disparity of cholestatic liver injury in multidrug resistance 2 gene knockout mice","volume":"66","author":"Li","year":"2017","journal-title":"Hepatology"},{"key":"2025092923000965000_3.3.e100227.42","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2013.01.003"},{"key":"2025092923000965000_3.3.e100227.43","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3009098","article-title":"A nontumorigenic variant of FGF19 treats cholestatic liver diseases","volume":"6","author":"Luo","year":"2014","journal-title":"Sci Transl Med"},{"key":"2025092923000965000_3.3.e100227.44","first-page":"1289","article-title":"Estrogen-induced cholestasis: pathogenesis and therapeuticimplications","volume":"60","author":"Chen","year":"2013","journal-title":"Hepatogastroenterology"},{"key":"2025092923000965000_3.3.e100227.45","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-79082-8","article-title":"Human extrahepatic and intrahepatic cholangiocyte organoids show region-specific differentiation potential and model cystic fibrosis-related bile duct disease","volume":"10","author":"Verstegen","year":"2020","journal-title":"Sci Rep"},{"key":"2025092923000965000_3.3.e100227.46","doi-asserted-by":"crossref","DOI":"10.1242\/bio.058678","article-title":"Specificity and off-target effects of AAV8-TBG viral vectors for the manipulation of hepatocellular gene expression in mice","volume":"10","author":"Kiourtis","year":"2021","journal-title":"Biol Open"}],"container-title":["eGastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/egastro-2025-100227","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T06:00:26Z","timestamp":1759212026000},"score":1,"resource":{"primary":{"URL":"http:\/\/egastroenterology.bmj.com\/lookup\/doi\/10.1136\/egastro-2025-100227"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":46,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2025,9,29]]},"published-print":{"date-parts":[[2025,7]]}},"alternative-id":["10.1136\/egastro-2025-100227"],"URL":"https:\/\/doi.org\/10.1136\/egastro-2025-100227","relation":{},"ISSN":["2766-0125","2976-7296"],"issn-type":[{"value":"2766-0125","type":"print"},{"value":"2976-7296","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7]]}}}